Form 4: Dolby Laboratories Director Simon Segars Reports Acquisition of Restricted Stock Units
SEC Form 4 Filing
Director Simon Segars reports the acquisition of 3,140 restricted stock units in Dolby Laboratories, Inc.
Summary
- On February 4, 2025, Simon Segars, a director of Dolby Laboratories, Inc., acquired 3,140 restricted stock units (RSUs).
- These RSUs were granted under the company's 2020 Stock Plan.
- Each RSU represents a contingent right to receive one share of Dolby's Class A Common Stock upon vesting.
- Vesting will occur on the earlier of the first anniversary of the grant date or the day before the 2026 annual meeting, contingent on continued service as a board member.
- Following the transaction, Segars beneficially owns 43,242 shares, including the 3,140 shares underlying the unvested RSUs.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. It reflects a standard transaction (granting of RSUs) that aligns director interests with shareholders, which is generally viewed favorably.
Positives
- The grant of restricted stock units to a director aligns their interests with those of the shareholders.
- Continued service as a board member is required for vesting, incentivizing ongoing commitment.
Future Outlook
The vesting of the restricted stock units is contingent upon the director's continued service on the board, suggesting an expectation of ongoing involvement.
Industry Context
This is a standard practice for compensating and incentivizing board members in publicly traded companies.
Comparison to Industry Standards
- Granting restricted stock units to directors is a common practice among publicly traded companies to align their interests with shareholders.
- The vesting schedules, typically tied to continued service, are also standard in the industry.
- Companies like Apple, Microsoft, and Google also use similar equity-based compensation for their board members.
Stakeholder Impact
- The acquisition of restricted stock units by a director can positively influence shareholder confidence by aligning management's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/04/2025 | Date of transaction: Simon Segars acquired 3,140 restricted stock units. |
| 02/04/2026 | Potential vesting date: First anniversary of the grant date. |
| 2026 Annual Meeting | Potential vesting date: The day immediately preceding the date of Issuer's 2026 annual meeting of stockholders. |
| 02/06/2025 | Date of Form 4 filing. |
Keywords
Form 4, Simon Segars, Dolby Laboratories, DLB, restricted stock units, RSUs, beneficial ownership, director, stock plan, vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.